Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 24/12/20141 min de lecture
Rare Pediatric Disease Priority Review Vouchers; Extension of Comment Period
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is extending the comment period for the notice of availability (NOA) that appeared in the Federal Register of November 17, 2014. In the NOA, FDA requested comments on the Agency's implementation of the Rare Pediatric Disease Priority Review Vouchers Program. This action will allow interested persons additional time to submit comments.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →